MRT5407
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MRT5407, covering 2025-01-24 to 2025-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older [Phase 1, Phase 2]